Israel Englander’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-113,657
Closed -$22.9K 6784
2023
Q4
$22.9K Buy
113,657
+56,785
+100% +$22.2K ﹤0.01% 5611
2023
Q3
$39.6K Sell
56,872
-153,691
-73% -$99.7K ﹤0.01% 5528
2023
Q2
$187K Buy
210,563
+23,213
+12% +$19.7K ﹤0.01% 5142
2023
Q1
$141K Buy
187,350
+9,499
+5% +$12.4K ﹤0.01% 5306
2022
Q4
$205K Sell
177,851
-250,349
-58% -$207K ﹤0.01% 5323
2022
Q3
$377K Buy
428,200
+235,097
+122% +$285K ﹤0.01% 5199
2022
Q2
$216K Sell
193,103
-332,650
-63% -$285K ﹤0.01% 5596
2022
Q1
$731K Sell
525,753
-284,837
-35% -$609K ﹤0.01% 4819
2021
Q4
$2.76M Sell
810,590
-566,690
-41% -$3.19M ﹤0.01% 3472
2021
Q3
$12.2M Buy
1,377,280
+996,088
+261% +$13.1M 0.01% 1816
2021
Q2
$6.47M Buy
381,192
+211,545
+125% +$3.1M ﹤0.01% 2416
2021
Q1
$2.27M Buy
169,647
+53,280
+46% +$1.2M ﹤0.01% 3423
2020
Q4
$3.35M Sell
116,367
-171,167
-60% -$4.63M ﹤0.01% 2816
2020
Q3
$8.57K Buy
+287,534
New +$8.73M 0.01% 1389

Other funds holding AFIB

Israel Englander's AFIB Position: Q1 2024 in Review

Israel Englander sold out of Acutus Medical Inc (AFIB) in Q1 2024, closing a stake of 113,657 shares — an estimated $22.9K sold.

Israel Englander first reported a position in AFIB in Q3 2020 and held it in 14 quarters. The position peaked at $12.2M in Q3 2021. 23 funds tracked by Wall St. Rank hold AFIB as of Q1 2024.

  • Israel Englander reported no remaining Acutus Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Israel Englander sold 113,657 Acutus Medical Inc shares in Q1 2024, an estimated $22.9K.
  • Israel Englander first reported a position in Acutus Medical Inc in Q3 2020 and held it in 14 quarters.
  • Israel Englander's Acutus Medical Inc position peaked at $12.2M in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.